Recent studies have suggested that TLR4 activation is involved in the amplification of fibrosis and TGF-β responses in SSc, and TLR4 activation has been implicated in other fibrotic diseases [17-19]. This evidence concerns the gene TGFB1 and systemic sclerosis.